Bioalpha Holdings Berhad Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Bioalpha Holdings Berhad has a total shareholder equity of MYR133.0M and total debt of MYR4.7M, which brings its debt-to-equity ratio to 3.5%. Its total assets and total liabilities are MYR170.1M and MYR37.1M respectively.
Belangrijke informatie
3.5%
Verhouding schuld/eigen vermogen
RM 4.66m
Schuld
Rente dekkingsratio | n/a |
Contant | RM 45.13m |
Aandelen | RM 132.96m |
Totaal verplichtingen | RM 37.14m |
Totaal activa | RM 170.10m |
Recente financiële gezondheidsupdates
Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) A Risky Investment?
Mar 19Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?
Oct 04Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) Using Debt Sensibly?
Jun 20Bioalpha Holdings Berhad (KLSE:BIOHLDG) Is Using Debt Safely
Mar 01Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?
Mar 03Recent updates
Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) A Risky Investment?
Mar 19Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?
Oct 04Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) Using Debt Sensibly?
Jun 20Bioalpha Holdings Berhad (KLSE:BIOHLDG) Is Using Debt Safely
Mar 01Why Bioalpha Holdings Berhad (KLSE:BIOHLDG) Could Be Worth Watching
Mar 29Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?
Mar 03Can You Imagine How Bioalpha Holdings Berhad's (KLSE:BIOHLDG) Shareholders Feel About The 42% Share Price Increase?
Jan 20How Much Is Bioalpha Holdings Berhad's (KLSE:BIOHLDG) CEO Getting Paid?
Nov 28Analyse van de financiële positie
Kortlopende schulden: BIOHLDG's short term assets (MYR63.9M) exceed its short term liabilities (MYR27.6M).
Langlopende schulden: BIOHLDG's short term assets (MYR63.9M) exceed its long term liabilities (MYR9.6M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: BIOHLDG has more cash than its total debt.
Schuld verminderen: BIOHLDG's debt to equity ratio has increased from 3.3% to 3.5% over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: BIOHLDG has sufficient cash runway for more than 3 years based on its current free cash flow.
Voorspelling contante baan: BIOHLDG has sufficient cash runway for 1.5 years if free cash flow continues to grow at historical rates of 10.5% each year.